MARTA MARIA
GARCIA CLEMENTE
Profesora Asociada en CC. Salud - LOSU
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (11)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565
2022
-
Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study
Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21
-
Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study
Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674
-
Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases
Archivos de Bronconeumologia, Vol. 58, pp. 39-50
2020
-
Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease
Archivos de Bronconeumologia, Vol. 56, Núm. 10, pp. 651-664
-
Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on
Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492
-
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
Respiratory Medicine, Vol. 170
2018
-
Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience
Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618
-
Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience
Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618
2016
-
Factors associated with fatality during the intensive phase of anti-tuberculosis treatment
PLoS ONE, Vol. 11, Núm. 8